Stay updated on Ribociclib Adjuvant Trial in Early Breast Cancer
Sign up to get notified when there's something new on the Ribociclib Adjuvant Trial in Early Breast Cancer page.

Latest updates to the Ribociclib Adjuvant Trial in Early Breast Cancer page
- ChecktodayChange DetectedThe ClinicalTrials.gov site footer now identifies the website as revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check7 days agoChange DetectedA notice announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.3%

- Check14 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check21 days agoChange DetectedA new version of the trial record updates its study status and contact/location information. The site revision label also advances.SummaryDifference0.3%

- Check42 days agoChange DetectedAdded two new sections to the record history, Contacts/Locations and Study Status, expanding access to key study details within the history view. The update appears alongside a new site revision (v3.7.0) and version 60 around mid‑September 2026.SummaryDifference0.3%

- Check63 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, signaling a platform update. There are no visible changes to the study history content.SummaryDifference0.0%

Stay in the know with updates to Ribociclib Adjuvant Trial in Early Breast Cancer
Enter your email address, and we'll notify you when there's something new on the Ribociclib Adjuvant Trial in Early Breast Cancer page.